Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Parasitic organism or component thereof or substance...
Patent
1978-08-21
1980-04-29
Tovar, Jose
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Parasitic organism or component thereof or substance...
548216, A61K 3142, C07D26344
Patent
active
042006422
ABSTRACT:
Novel spiro-oxazolidindiones useful as aldose reductase inhibitors and as therapeutic agents for the treatment of chronic diabetic complications are disclosed. Pharmaceutical compositions containing the novel compounds and a method of treating chronic diabetic complications are also disclosed.
REFERENCES:
patent: 3532744 (1970-10-01), Fletcher et al.
R. W. Stoughton J.A.C.S. 63 2376 (1941).
J. W. Clark-Lewis, Chemical Reviews 58, 63 (1958).
M. A. Spielman J.A.C.S. 66, 1244 (1944).
H. Naver et al. Bull. Soc. Chim. Fr. 1961, 1226 (1961).
Knuth Charles J.
Murphy Francis X.
Pfizer Inc.
Richardson Peter C.
Tovar Jose
LandOfFree
Spiro-oxazolidindiones does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Spiro-oxazolidindiones, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Spiro-oxazolidindiones will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1684065